Biotech
Vertex Pharmaceuticals
Vertex Pharmaceuticals raises $110B Public at $120B valuation
$110B
Total Raised
Public
Latest Round
1989
Founded
5500+
Employees
50 Northern Avenue, Boston, MA 02210
1 min read
Quick Facts
Valuation
$120B
Latest Round Size
$110B
Latest Round Date
January 2024
Vertex Pharmaceuticals: Public Funding Round
Vertex Pharmaceuticals has successfully raised $110B in Public funding, reaching a valuation of $120B.
Company Overview
Biotechnology company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: 50 Northern Avenue, Boston, MA 02210
- Founded: 1989
- Employees: 5500+
- Category: Biotech
Investment
Vertex Pharmaceuticals plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Key Investors
Public
Lead Investor
Verified investor in Public
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M